Evidence map›Paper›PMID 23849336›Full record

ArticleBMC infectious diseases2013

Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne bla(OXA-72) in Taiwan.

Shu-Chen Kuo, Su-Pen Yang, Yi-Tzu Lee, Han-Chuan Chuang, Chien-Pei Chen, Chi-Ling Chang, Te-Li Chen, Po-Liang Lu, Po-Ren Hsueh, Chang-Phone Fung

Abstract read
In one paragraph

Article in BMC infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Antimicrobial Resistance and Virulence ofAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Molecular Epidemiology of Carbapenem-ResistantMicrobial drug resistance (Larchmont, N.Y.) · 2022
    Article
  5. Article
  6. Article
  7. The Role of Uniform Meropenem Usage inAntibiotics (Basel, Switzerland) · 2021
    Article
  8. Dual Role ofAntimicrobial agents and chemotherapy · 2019
    Article
  9. Molecular Epidemiology of Emerging Carbapenem Resistance inAntimicrobial agents and chemotherapy · 2019
    Article
  10. Molecular Epidemiology of EmergingAntimicrobial agents and chemotherapy · 2018
    Article
  11. Frontiers in microbiology · 2018
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Acquired Class D β-Lactamases.Antibiotics (Basel, Switzerland) · 2014
    Review
  18. OXA β-lactamases.Clinical microbiology reviews · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shu-Chen KuoInstitute of Clinical Medicine, National Yang-Ming University, School of Medicine, Beitou District, Taipei 112, Taiwan.
Su-Pen Yang
Yi-Tzu Lee
Han-Chuan Chuang
Chien-Pei Chen
Chi-Ling Chang
Te-Li Chen
Po-Liang Lu
Po-Ren Hsueh
Chang-Phone Fung

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe systemic surveillance of imipenem-resistant Acinetobacter baumannii (IRAB) from multicenters in Taiwan revealed the emergence of isolates with bla(OXA-72). This study described their genetic makeup, mechanism of spread, and contribution to carbapenem resistance.

methodsTwo hundred and ninety-one non-repetitive isolates of A. baumannii were collected from 10 teaching hospitals from different geographical regions in Taiwan from June 2007 to September 2007. Minimal inhibitory concentrations (MICs) were determined by agar dilution. Clonality was determined by pulsed-field gel electrophoresis. Plasmid was extracted and digested by restriction enzymes, and subsequently analyzed by electrophoresis and Southern blot for bla(OXA-72). The flanking regions of bla(OXA-72) were determined by inverse PCR. The contribution of bla(OXA-72) to imipenem MIC was determined by transforming plasmids carrying bla(OXA-72) into imipenem-susceptible A. baumannii.

resultsAmong 142 IRAB in Taiwan, 27 harbored bla(OXA-72); 22 originated from Southern Taiwan, 5 from Central Taiwan, and none from Northern Taiwan. There were two major clones. The bla(OXA-72) was identified in the plasmids of all isolates. Two genetic structures flanking plasmid-borne bla(OXA-72) were identified and shared identical sequences in certain regions; the one described in previous literature was present in only one isolate, and the new one was present in the remaining isolates. Introduction of bla(OXA-72) resulted in an increase of imipenem MIC in the transformants. The overexpression of bla(OXA-72) mRNA in response to imipenem further supported the contribution of bla(OXA-72).

conclusionsIn conclusion, isolates with new plasmid-borne blaOXA-72 were found to be disseminated successfully in Southern Taiwan. The spread of the resistance gene depended on clonal spread and dissemination of a new plasmid. Bla(OXA-72) in these isolates directly led to their imipenem-resistance.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial Agentsbeta-Lactamasesbeta-Lactam ResistanceBlotting, SouthernElectrophoresis, Gel, Pulsed-FieldHumansImipenemMicrobial Sensitivity TestsPhylogenyPlasmidsPolymerase Chain ReactionRetrospective StudiesTaiwanAnti-Bacterial Agentsbeta-LactamasesImipenem

Identifiers

PMID23849336
PMCPMC3728158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.